Teladoc Health (NYSE:TDOC) Given New $7.00 Price Target at Oppenheimer

Teladoc Health (NYSE:TDOC) had its price target cut by Oppenheimer from $12.00 to $7.00 in a research report report published on Tuesday,Benzinga reports. They currently have an outperform rating on the health services provider’s stock.

Other research analysts also recently issued research reports about the company. Zacks Research downgraded Teladoc Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. TD Cowen reduced their price target on Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a research report on Thursday, February 26th. Barclays began coverage on Teladoc Health in a research note on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 price target on the stock. Canaccord Genuity Group cut their target price on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Finally, BMO Capital Markets decreased their target price on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating on the stock in a research note on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and an average target price of $7.56.

Teladoc Health Stock Down 1.4%

Shares of NYSE TDOC opened at $5.09 on Tuesday. The stock has a market capitalization of $908.06 million, a P/E ratio of -4.46 and a beta of 2.13. Teladoc Health has a one year low of $4.40 and a one year high of $9.90. The firm’s 50 day simple moving average is $5.90 and its two-hundred day simple moving average is $7.17. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.77 and a quick ratio of 2.67.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The firm had revenue of $642.27 million during the quarter, compared to analyst estimates of $635.33 million. During the same period in the previous year, the business posted ($0.28) EPS. The business’s quarterly revenue was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. As a group, analysts expect that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $7.63, for a total transaction of $130,762.94. Following the transaction, the chief executive officer directly owned 201,036 shares of the company’s stock, valued at approximately $1,533,904.68. The trade was a 7.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.58% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently modified their holdings of the stock. IFP Advisors Inc boosted its position in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Teladoc Health by 177.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 2,810 shares during the period. Aster Capital Management DIFC Ltd boosted its position in shares of Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 2,425 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Teladoc Health during the fourth quarter valued at approximately $45,000. Finally, Bayforest Capital Ltd purchased a new stake in Teladoc Health in the third quarter worth $58,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.